Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-21
2005-06-21
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S183000, C548S186000, C548S189000
Reexamination Certificate
active
06908939
ABSTRACT:
Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPARγ receptor, such biaromatic ligand having the structural formula (I):and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.
REFERENCES:
patent: 1 067 109 (2001-01-01), None
patent: 2 812 876 (2002-02-01), None
patent: WO 01/14349 (2001-03-01), None
Ishihara et al., 2000, CAS:133:58799.
Nomura et al., “(3-Substituted Benzyl)Thiazolidine-2,4-diones as Structurally New Antihyperglycemic Agents”, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 4, Feb. 22, 1999, Elsevier Science Ltd., ppgs 533-538.
Bernardon Jean-Michel
Clary Laurence
Terranova Eric
Burns Doane Swecker & Mathis L.L.P.
Desai Rita
Galderma Research & Development S.N.C.
Shiao Robert
LandOfFree
Biaromatic ligand activators of PPARγ receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaromatic ligand activators of PPARγ receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaromatic ligand activators of PPARγ receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522306